How would you treat a patient with EGFR+ oligo-metastatic lung adenocarcinoma status post resection of the primary and metastatic sites?

Topics: Thoracic Malignancies • Medical Oncology • NCI-CCC Tumor Board Question • Indiana University

Would you give adjuvant chemotherapy or start osimertinib?

Answer from: Medical Oncologist at Academic Institution

This is a somewhat challenging question - on the one hand, the patient has metastatic (albeit "oligo" metastatic) cancer and systemic treatment with osimertinib is clearly indicated and appropriate for metastatic EGFR mutant lung cancers. On the other hand, all known disease has been resected, and t...

Comments

Medical Oncologist at St Agnes Healthcare
Would you withhold osimertinib if the metastatic s...

Medical Oncologist at Northern Arizona Tumor Inst
Continue osimertinib.

Related Questions